N6 -methyladenosine RNA demethylase FTO regulates extracellular matrix-related genes and promotes pancreatic cancer cell migration and invasion
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd..
Pancreatic cancer (PC) is a deadly disease, and its post-transcriptional gene regulation mechanism remains unclear. The abundant extracellular matrix (ECM) in PC plays an important role in tumor progression. This study is the first to focus on the role of N6 -methyladenosine (m6 A) RNA methylation, an emerging post-transcriptional regulatory mechanism, in the regulation of the ECM in PC. Here, we found that ADAMTS2, COL12A1, and THBS2 were associated with the prognosis of PC by comprehensive analysis of differentially expressed genes from two independent GEO expression profile datasets and m6 A-related genes in RMVar database (PAAD). GO and KEGG enrichment analysis found that these m6 A-related targets are chiefly functionally concentrated in the ECM region and participate in ECM signal transduction. Correlation analysis revealed that these genes can be regulated by the demethylase FTO. Cell biology function assays showed that knockdown of FTO-inhibited PC cell abilities to migrate and invade in vitro. qRT-PCR and MeRIP experiments showed that after knockdown of FTO, the mRNA levels of ADAMTS2, COL12A1, and THBS2 and their m6 A modification levels were significantly reduced. These results indicate that m6 A RNA demethylation is associated with the regulation of ECM in PC. In conclusion, m6 A RNA demethylase FTO regulates ECM-related genes and promotes PC cell abilities to migrate and invade, our work provides a new perspective on the molecular mechanism of PC progression.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Cancer medicine - 12(2023), 3 vom: 26. Feb., Seite 3731-3743 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Wei [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 24.02.2023 Date Revised 13.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/cam4.5054 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM343997363 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM343997363 | ||
003 | DE-627 | ||
005 | 20231227130849.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/cam4.5054 |2 doi | |
028 | 5 | 2 | |a pubmed24n1225.xml |
035 | |a (DE-627)NLM343997363 | ||
035 | |a (NLM)35879877 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Wei |e verfasserin |4 aut | |
245 | 1 | 0 | |a N6 -methyladenosine RNA demethylase FTO regulates extracellular matrix-related genes and promotes pancreatic cancer cell migration and invasion |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.02.2023 | ||
500 | |a Date Revised 13.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. | ||
520 | |a Pancreatic cancer (PC) is a deadly disease, and its post-transcriptional gene regulation mechanism remains unclear. The abundant extracellular matrix (ECM) in PC plays an important role in tumor progression. This study is the first to focus on the role of N6 -methyladenosine (m6 A) RNA methylation, an emerging post-transcriptional regulatory mechanism, in the regulation of the ECM in PC. Here, we found that ADAMTS2, COL12A1, and THBS2 were associated with the prognosis of PC by comprehensive analysis of differentially expressed genes from two independent GEO expression profile datasets and m6 A-related genes in RMVar database (PAAD). GO and KEGG enrichment analysis found that these m6 A-related targets are chiefly functionally concentrated in the ECM region and participate in ECM signal transduction. Correlation analysis revealed that these genes can be regulated by the demethylase FTO. Cell biology function assays showed that knockdown of FTO-inhibited PC cell abilities to migrate and invade in vitro. qRT-PCR and MeRIP experiments showed that after knockdown of FTO, the mRNA levels of ADAMTS2, COL12A1, and THBS2 and their m6 A modification levels were significantly reduced. These results indicate that m6 A RNA demethylation is associated with the regulation of ECM in PC. In conclusion, m6 A RNA demethylase FTO regulates ECM-related genes and promotes PC cell abilities to migrate and invade, our work provides a new perspective on the molecular mechanism of PC progression | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a RNA methylation | |
650 | 4 | |a extracellular matrix | |
650 | 4 | |a m6A | |
650 | 4 | |a pancreatic cancer | |
650 | 7 | |a Adenosine |2 NLM | |
650 | 7 | |a K72T3FS567 |2 NLM | |
650 | 7 | |a Alpha-Ketoglutarate-Dependent Dioxygenase FTO |2 NLM | |
650 | 7 | |a EC 1.14.11.33 |2 NLM | |
650 | 7 | |a FTO protein, human |2 NLM | |
650 | 7 | |a EC 1.14.11.33 |2 NLM | |
700 | 1 | |a He, Ying |e verfasserin |4 aut | |
700 | 1 | |a Wu, Lun |e verfasserin |4 aut | |
700 | 1 | |a Zhai, Lu-Lu |e verfasserin |4 aut | |
700 | 1 | |a Chen, Long-Jiang |e verfasserin |4 aut | |
700 | 1 | |a Yao, Li-Chao |e verfasserin |4 aut | |
700 | 1 | |a Yu, Kai-Huan |e verfasserin |4 aut | |
700 | 1 | |a Tang, Zhi-Gang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer medicine |d 2012 |g 12(2023), 3 vom: 26. Feb., Seite 3731-3743 |w (DE-627)NLM224388460 |x 2045-7634 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2023 |g number:3 |g day:26 |g month:02 |g pages:3731-3743 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/cam4.5054 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2023 |e 3 |b 26 |c 02 |h 3731-3743 |